Loading…

Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products

Elevated levels of reactive α,β-unsaturated aldehydes (e.g. malondialdehyde, 4-hydroxynonenal and acrolein) in the affected tissues of various degenerative conditions suggest these substances are active propagators of the disease process. One experimental approach to attenuating damage by these inte...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology (Amsterdam) 2002-12, Vol.181, p.229-236
Main Authors: Burcham, Philip C., Kaminskas, Lisa M., Fontaine, Frank R., Petersen, Dennis R., Pyke, Simon M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Elevated levels of reactive α,β-unsaturated aldehydes (e.g. malondialdehyde, 4-hydroxynonenal and acrolein) in the affected tissues of various degenerative conditions suggest these substances are active propagators of the disease process. One experimental approach to attenuating damage by these intermediates employs ‘aldehyde-sequestering drugs’ as sacrificial nucleophiles, thereby sparing cell macromolecules and perhaps slowing disease progression. Drugs with demonstrated trapping activity toward lipid-derived aldehydes include various amine compounds such as aminoguanidine, carnosine and pyridoxamine. We have focused on identifying scavengers of acrolein, perhaps the most toxic aldehyde formed during lipid peroxidation cascades. Various phthalazine compounds (hydralazine and dihydralazine) were found to trap acrolein readily, forming hydrazone derivatives in a rapid Schiff-type reaction. These compounds strongly protect against acrolein-mediated toxicity in isolated hepatocytes.
ISSN:0300-483X
1879-3185
DOI:10.1016/S0300-483X(02)00287-1